Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01738802 · ClinicalTrials.gov registry record · NA

The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes

A NA study of Type 2 Diabetes, sponsored by Walter Reed National Military Medical Center.

Completed
Registry status
NA
Development phase
111
Enrollment target
2
Study locations

NCT01738802 is a NA study of Type 2 Diabetes that has completed, run by Walter Reed National Military Medical Center. The registered enrollment target is 111 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01738802, a NA study of Type 2 Diabetes, has completed, sponsored by Walter Reed National Military Medical Center.

COMPLETED
Registry status
NA
Development phase
111 participants
Enrollment target
2
Study locations

Study Summary

This study is evaluating the impact of antioxidant supplements on blood sugar control and cardiovascular risk factors in adults over the age of 50 with at 3 months of Type 2 diabetes. The investigators hypothesize that daily supplementation with a multiple micronutrient formulation containing dietary and endogenous antioxidants in combination with usual care will reduce markers of oxidative stress and inflammation in Type 2 diabetes.

Conditions Studied

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Anti-oxidant and micronutrient

Study Locations (2)

Maryland

  • Walter Reed National Military Medical Center - Bethesda
  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2012-01
Est. Completion 2016-04
Phase NA

What the Registry Record Tells You About NCT01738802

The ClinicalTrials.gov registry entry for NCT01738802 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01738802 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01738802 about?

NCT01738802 is a clinical study titled "The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes". This study is evaluating the impact of antioxidant supplements on blood sugar control and cardiovascular risk factors in adults over the age of 50 with at 3 months of Type 2 diabetes. The investigators hypothesize that daily supplementation with a multiple micronutrient formulation containing dietar...

What is the current status of trial NCT01738802?

This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2012-01. Estimated completion is 2016-04.

What conditions does trial NCT01738802 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT01738802?

The interventions under investigation include: Placebo (DRUG), Anti-oxidant and micronutrient (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01738802?

This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01738802 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.